| DNA lentivector for transduction information: |
GENTAUR suggests to use our ABM packaging mix LV003 of second generation virusses or the LV053, This DNA can alos be used for packaging into Lentiviral particles for high efficiency transduction and stably integrated expressions, Vectors with selection markers like kanamycin, our 3rd Generation Packaging mixture, pLenti lentiviral plasmids DNAs are stored in 10milliMolar Tris/HCI with 1mM EDTA at a pH of 8 at -25 C, puromycin or cumate are available, Lentiveral packaging plasmid DNA for non-viral plasmid transfection and direct use in plasmid expression |
| Properties: |
Depending on the epitopes used human ELISA kits can be cross reactive to many other species, Mainly analyzed are human serum, Modern , cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies, human cell culture supernatants and biological samples, plasma, primarily , saliva, urine, , (Homo sapiens, Homo sapiens sapiens), Human proteins, humans , ssp |
| Gene target: |
HPGD Lentiviral Vector (EF1a) (pLenti-GIII-EF1a) |
| Short name: |
HPGD Lentiviral Vector ( ) (EF1a) (pLenti-GIII-EF1a) |
| Technique: |
Vectors |
| Species: |
Humans, Human |
| Alternative name: |
sapiens) (EF1a) (pLenti-GIII-EF1a), hydroxyprostaglandin dehydrogenase 15-(Nicotinamide adenine dinucleotide) Lentiviral integrating Desoxyribonucleic acid sequence (H |
| Alternative to gene target: |
15-PGDH and PGDH and PGDH1 and PHOAR1 and SDR36C1, BT, HPGD and IDBG-44946 and ENSG00000164120 and 3248, Hpgd and IDBG-155950 and ENSMUSG00000031613 and 15446, NAD+ binding, Plasma membranes, this GO :0003824 and catalytic activity and molecular function this GO :0004957 and prostaglandin E receptor activity and molecular function this GO :0005829 and cytosol and cellular component this GO :0006693 and prostaglandin metabolic process and biological process this GO :0007179 and transforming growth factor beta receptor signaling pathway and biological process this GO :0007565 and female pregnancy and biological process this GO :0007567 and parturition and biological process this GO :0008152 and metabolic process and biological process this GO :0016323 and basolateral plasma membrane and cellular component this GO :0016404 and 15-hydroxyprostaglandin dehydrogenase (NAD+) activity and molecular function this GO :0016491 and oxidoreductase activity and molecular function this GO :0019369 and arachidonic acid metabolic process and biological process this GO :0019371 and cyclooxygenase pathway and biological process this GO :0019372 and lipoxygenase pathway and biological process this GO :0030728 and ovulation and biological process this GO :0042803 and protein homodimerization activity and molecular function this GO :0044281 and small molecule metabolic process and biological process this GO :0045786 and negative regulation of cell cycle and biological process this GO :0050662 and coenzyme binding and molecular function this GO :0051287 and NAD binding and molecular function this GO :0055114 and oxidation-reduction process and biological process this GO :0070062 and extracellular vesicular exosome and cellular component this GO :0070403 and NAD+ binding and molecular function this GO :0070493 and thrombin receptor signaling pathway and biological process this GO :0097070 and ductus arteriosus closure and biological process this GO :2001300 and lipoxin metabolic process and biological process, this GO :0003824 : catalytic activity, this GO :0003824 : catalytic activity and also this GO :0004957 : prostaglandin E receptor activity and also this GO :0016404 : 15-hydroxyprostaglandin dehydrogenase (NAD+) activity and also this GO :0016491 : oxidoreductase activity and also this GO :0042803 : protein homodimerization activity and also this GO :0050662 : coenzyme binding and also this GO :0051287 : NAD binding and also this GO :0070403 : NAD+ binding, this GO :0004957 : prostaglandin E receptor activity, this GO :0016404 : 15-hydroxyprostaglandin dehydrogenase (NAD+) activity, this GO :0016491 : oxidoreductase activity, this GO :0042803 : protein homodimerization activity, this GO :0050662 : coenzyme binding, this GO :0051287 : NAD binding, this GO :0070403 : NAD+ binding, 43717 and IDBG-629346 and ENSBTAG00000025942 and 512259, hydroxyprostaglandin dehydrogenase 15-(NAD) |
| Identity: |
5154 |
| Gene: |
HPGD |
More about : HPGD |
| Long gene name: |
hydroxyprostaglandin dehydrogenase 15-(NAD) |
| Synonyms: |
SDR36C1 |
| Synonyms name: |
member 1 , short chain dehydrogenase/reductase family 36C |
| Locus: |
4q34, 1 |
| Discovery year: |
1991-07-16 |
| Entrez gene record: |
3248 |
| Pubmed identfication: |
19027726 |
| Classification: |
Short chain dehydrogenase/reductase superfamily |
| Havana BLAST/BLAT: |
OTTHUMG00000160772 |